Skip to main content
Senate reauthorizes FDA user fees
8/3/2017

The Senate voted 94-1 in favor of legislation renewing the FDA's authority to collect user fees from drug and device makers. The bill, which already cleared the House, did not include language allowing the importation of drugs from Canada, and a separate bill regarding patients' rights to try experimental treatments was passed earlier in the day.

Full Story: